Allergen Specific Cluster Subcutaneous Immunotherapy in Nasobronchial Allergy.
Not Applicable
- Conditions
- Health Condition 1: null- patients suffering from allergic rhinits and/or bronchial asthma
- Registration Number
- CTRI/2014/03/004487
- Lead Sponsor
- KIMS Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
Patients between age group 18 â?? 60 years who have Allergic Rhinitis and Allergic Bronchial Asthma and who are sensitive to aeroallergens.
Exclusion Criteria
1.Those who are not willing to take part in the study.
2.Patients with Severe Asthma, Pregnancy, Ischemic Heart Disease, High Blood Pressure, receiving Immunosuppressive medications & Beta-Blockers, and other Immune Disorders.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method completion of six weeks cluster cycle without adverse outcomes.Timepoint: six weeks
- Secondary Outcome Measures
Name Time Method changes in symptom score and medication score at the end of one year. <br/ ><br>physician evaluation of symptoms of nasobronchial allergyTimepoint: one year